This opportunity is made possible through BioCT’s partnership with MassBio.
The life sciences’ premier innovation summit, MassBio’s State of Partnering is an interactive and immersive digital experience that connects emerging companies with the partners, insights, and resources they need to take their businesses to the next level.
Each day of May 10 – 12, a new biopharma (Bayer, Ipsen, and Takeda) will present its innovation strategy to the public:
On May 13 and 14, early-stage companies will participate in the innovator bootcamp, an intensive deep-dive into the tools and resources you need to grow your company. Experts from Bayer, KPMG, Marsh and McLennan, Morgan Stanley, and Rothwell Fig will share the latest industry insights and guidance with attendees.
Agenda
Apply for a State of Possible Partner Meeting
Eligibility Guidelines – State of Partnering biopharma companies are looking to connect with early-stage companies with groundbreaking ideas or next-generation technologies that fit within their therapeutic areas of focus.
Note that not all applicants will be selected for a one-on-one meeting during the State of Partnering 2021, but by submitting your application, you’ll join MassBio’s innovation network, where you’ll be able to access other growth opportunities for your company.
Please note: To register for this event, you will need to create a MassBio account. To do so, please click here.